Core Laboratories Inc (CLB)
18.90
-0.38
(-1.97%)
USD |
NYSE |
Oct 31, 16:00
18.91
+0.01
(+0.05%)
Pre-Market: 20:00
Core Laboratories CAPEX to Revenue (Annual)
CAPEX to Revenue (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical CAPEX to Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | -- |
| December 31, 2022 | -- |
| December 31, 2021 | -- |
| December 31, 2020 | -- |
| December 31, 2019 | -- |
| December 31, 2018 | -- |
| December 31, 2017 | -- |
| December 31, 2016 | -- |
| December 31, 2015 | -- |
| December 31, 2014 | -- |
| December 31, 2013 | -- |
| December 31, 2012 | -- |
| December 31, 2011 | -- |
| December 31, 2010 | -- |
| December 31, 2009 | -- |
| Date | Value |
|---|---|
| December 31, 2008 | -- |
| December 31, 2007 | -- |
| December 31, 2006 | -- |
| December 31, 2005 | -- |
| December 31, 2004 | -- |
| December 31, 2003 | -- |
| December 31, 2002 | -- |
| December 31, 2001 | -- |
| December 31, 2000 | -- |
| December 31, 1999 | -- |
| December 31, 1998 | -- |
| December 31, 1997 | -- |
| December 31, 1996 | -- |
| December 31, 1995 | -- |
Capex to Revenue Definition
The Capex to Revenue ratio measures a company's investments in property, plant, equipment, and other capital assets to its total sales. The ratio shows how aggressively the company is re-investing its revenue back into productive assets.